Drugs that Exacerbate Psoriasis

Gladman D.D. , Blake R. , Brubacher B. , Farewell V.T. Chloroquine Therapy in Psoriatic Arthritis. J Rheumatol. 1992; 19: 1724–1726.

Gray R.G. Hydroxychloroquine Provocation of Psoriasis. J Rheumatol. 1985; 12: 391.

Kuflik E.G. Effect of Antimalarial Drugs on Psoriasis. Cutis. 1980; 26: 153–155.

Luzar M.J. Hydroxychloroquine in Psoriatic Arthropathy: Exacerbations of Psoriatic Skin Lesions. J Rheumatol. 1982; 9: 462–464.

Wolf R. , Ruocco V. Triggered Psoriasis. Adv Exp Med Biol. 1999; 455: 221–225.

Welsch M.J. Acute Pustular Psoriasis Complicated by Leukocytoclastic Vasculitis. J Drugs Dermatol. 2003; 2: 193–197.

Chan H.H. , Wing Y. , Su R. , Van K.C. , Lee S. A Control Study of the Cutaneous Side Effects of Chronic Lithium Therapy. J Affect Disord. 2000; 57: 107–113.

Sasaki T. , Saito S. , Aihara M. , Ohsawa J. , Ikezawa Z. Exacerbation of Psoriasis During Lithium Treatment. J Dermatol. 1989; 16: 59–63.

Allan S.J. , Kavanagh G.M. , Herd R.M. , Savin J.A. The Effect of Inositol Supplements on the Psoriasis of Patients Taking Lithium: a Randomized, Placebo-Controlled Trial. Br J Dermatol. 2004; 150: 966–969.

Gold M.H. , Holy A.K. , Roenigk HH Jr. Beta-Blocking Drugs and Psoriasis. A Review of Cutaneous Side Effects and Retrospective Analysis of Their Effects on Psoriasis. J Am Acad Dermatol. 1988; 19: 837–841.

Ikai K. Exacerbation and Induction of Psoriasis by Angiotensin-Converting Enzyme Inhibitors. J Am Acad Dermatol. 1995; 32: 819.

Marquart-Elbaz C. , Grosshans E. , Lipsker D. , Lipsker D. Sartans, Angiotensin II Receptor Antagonists, Can Induce Psoriasis. Br J Dermatol. 2002; 147: 617–618.

Brodell R.T. , Williams L. A Corticosteroid-Induced Flare of Psoriasis. How to Control or, Better Yet, Avoid. Postgrad Med. 1999; 106: 31–32.

Ryan T.J. , Baker H. Systemic Corticosteroids and Folic Acid Antagonists in the Treatment of Generalized Pustular Psoriasis. Evaluation and Prognosis Based on the Study of 104 Cases. Br J Dermatol. 1969; 81: 134–145.

Cho S.G. , Park Y.M. , Moon H. , Kim K.M. , Bae S.S. , Kim G.B. , Cho H.S. , Kim C.C. , Lee K.S. Psoriasiform Eruption Triggered by Recombinant Granulocyte-Macrophage Colony Stimulating Factor (RGM-CSF) and Exacerbated by Granulocyte Colony Stimulating Factor (RG-CSF) in a Patient With Breast Cancer. J Korean Med Sci. 1998; 13: 685–688.

Feliu J. , Diaz R. , Contreras F. , Casado M. , Espinosa E. , Baron M.G. Worsening Psoriasis After Treatment With G-CSF in a Patient With Small-Cell Lung Cancer. J Natl Cancer Inst. 1997; 89: 1315–1316.

Kelly R. , Marsden R.A. , Bevan D. Exacerbation of Psoriasis with GM-CSF Therapy. Br J Dermatol. 1993; 128: 468–469.

Ladoyanni E. , Nambi R. Psoriasis Exacerbated by Interferon-Alpha in a Patient with Chronic Myeloid Leukemia, J Drugs Dermatol. 2005; 4: 221–222.

Ketikoglou I. , Karatapanis S. , Elefsiniotis I. , Kafiri G. , Moulakakis A. Extensive Psoriasis Induced by Pegylated Interferon Alpha-2b Treatment for Chronic Hepatitis B. Eur J Dermatol. 2005; 15: 107–109.

Katayama H. , Kawada A. Exacerbation of Psoriasis Induced by Indomethacin. J Dermatol. 1981; 8: 323–327.

Ben-Chetrit E. , Rubinow A. Exacerbation of Psoriasis by Ibuprofen. Cutis 1986; 38: 45.

Sendagorta E. , Allegue F. , Rocamora A. , Ledo A. Generalized Pustular Psoriasis Precipitated by Diclofenac and Indomethacin. Dermatologica. 1987; 175: 300–301.

Clark D.W. , Coulter D.M. Psoriasis Associated With Rofecoxib. Litt JZ. Drug Eruption Reference Manual Including Drug Interactions; 2004.

Litt J.Z. Drug Eruption Reference Manual Including Drug Interactions. 2004.